The 2026 guide to private healthcare in the UK
How to navigate consultations, costs, insurance and choosing the right specialist in the UK private market - without becoming your own healthcare strategist.
The Pulse Atlas Journal
Notes from the editorial board on conditions, wellness, tests and the practice of medicine - clinically reviewed, written for patients, never sponsored.
How to navigate consultations, costs, insurance and choosing the right specialist in the UK private market - without becoming your own healthcare strategist.
12 considered reads.
12 showing
AF is the most common sustained heart-rhythm condition in the UK. Modern rhythm-control, ablation and the new anticoagulants - explained.
Wearable-led sleep audits used to be a curiosity. Now they sit in the same diagnostic toolkit as full-body MRI - and they are surprisingly accurate.
A grown-up look at what private full-body MRI does well, where it overpromises, and how to think about the inevitable incidental findings.
Semaglutide. Tirzepatide. Retatrutide. Cutting through the news cycle to the patient questions that actually matter - and the ones still unanswered.
Updated single assessment framework, new evidence categories and tighter inspection cycles. What changes for patients, what changes for clinics.
Sarah had spent three weeks navigating private listings on her own. Then a single enquiry, and a Harley Street cardiologist on the phone the same afternoon.
A printable checklist from our editorial board - the questions our consultants wish patients asked, before pricing or scheduling.
Continuous glucose monitoring, structured education, the new dual-agonist injectables - what good private diabetes care looks like in 2026.
Sleep is downstream of light, alcohol, late meetings and ambient noise. A practical guide for people who can fix three of those four.
Twenty-marker panels are now standard. Sixty-marker panels are a thing. Here is what is genuinely useful - and what is sold on novelty.
Second-read AI on chest CT and breast screening is now in routine London private practice. The accuracy claims, the safety net, and the quiet caveats.
Primary prevention, secondary prevention, the side-effect myths, and how the QRISK4 update has shifted the conversation.
No articles in this category yet.
Subscribe
A monthly clinical brief from the editorial board: the best new piece, a translation of any new UK guidance, and a quiet roundup of the journal.